A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study

• Main Authors: Huimin Zhang (Author), Peiling Xie (Author), Zhuoying Li (Author), Rong Huang (Author), Weiliang Feng (Author), Yanan Kong (Author), Feng Xu (Author), Lin Zhao (Author), Qingkun Song (Author), Jing Li (Author), Baoning Zhang (Author), Jinhu Fan (Author), Youlin Qiao (Author), Xiaoming Xie (Author), Shan Zheng (Author), Jianjun He (Author), Ke Wang (Author)
• Format: Book
• Published: BMC, 2019-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The concordance rate of human epidermal growth factor receptor 2 (HER2) status between core needle biopsy (CNB) and subsequent excisional biopsies of the same tumor varies from 81 to 96%, which may cause inappropriate neoadjuvant therapy that impair the potential benefit from HER...